monitoring continuum
DESCRIPTION
Monitoring Continuum. ISSUE-3. Atrial Fibrillation Classification. Cryptogenic Stroke and Atrial Fibrillation. AF Management Guidelines Considerations for Anticoagulant Selection. SURPRISE TRIAL. Time from Cryptogenic Stroke to AF Detection by ICM Results from SURPRISE study. CRYSTAL AF. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/1.jpg)
![Page 2: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/2.jpg)
![Page 3: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/3.jpg)
Monitoring Continuum
![Page 4: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/4.jpg)
ISSUE-3
![Page 5: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/5.jpg)
Atrial Fibrillation Classification
![Page 6: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/6.jpg)
Cryptogenic Stroke and Atrial Fibrillation
![Page 7: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/7.jpg)
AF Management GuidelinesConsiderations for Anticoagulant
Selection
![Page 8: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/8.jpg)
SURPRISE TRIAL
![Page 9: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/9.jpg)
Time from Cryptogenic Stroke to AF Detection by ICMResults from SURPRISE study
![Page 10: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/10.jpg)
CRYSTAL AF
![Page 11: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/11.jpg)
Atrial Fibrillation Duration in ICM Arm at 12 Months (N = 29)
![Page 12: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/12.jpg)
Feedback Loop for Care Team
![Page 13: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/13.jpg)
Clinical ScenarioPresentation and Work-up
![Page 14: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/14.jpg)
Evaluation for Cryptogenic Stroke
![Page 15: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/15.jpg)
Clinical ScenarioContinuous Monitoring
![Page 16: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/16.jpg)
Current and Emerging Indications for Implantable Cardiac Monitoring
![Page 17: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/17.jpg)
AF Burden During Blanking Period Predicts Response to RFA at 12
Months
![Page 18: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/18.jpg)
DISCERN AFProspective Multicenter Study
![Page 19: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/19.jpg)
Abbreviations
![Page 20: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/20.jpg)
Abbreviations (cont)
![Page 21: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/21.jpg)
References
![Page 22: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/22.jpg)
References (cont)
![Page 23: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/23.jpg)
References (cont)
![Page 24: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/24.jpg)
References (cont)
![Page 25: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/25.jpg)
References (cont)
![Page 26: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/27.jpg)
References (cont)
![Page 28: Monitoring Continuum](https://reader033.vdocument.in/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/28.jpg)
References (cont)